Solid Tumor-Targeting Theranostic Polymer Nanoparticle in Nuclear Medicinal Fields

Polymer nanoparticles can be prepared by self-assembling of amphiphilic polymers, and various types of molecular assemblies have been reported. In particular, in medicinal fields, utilization of these polymer nanoparticles as carriers for drug delivery system (DDS) has been actively tried, and some...

Full description

Bibliographic Details
Main Authors: Akira Makino, Shunsaku Kimura
Format: Article
Language:English
Published: Hindawi Limited 2014-01-01
Series:The Scientific World Journal
Online Access:http://dx.doi.org/10.1155/2014/424513
id doaj-c2a5597aa7534f07a6f7c5f823bd93b8
record_format Article
spelling doaj-c2a5597aa7534f07a6f7c5f823bd93b82020-11-25T00:46:30ZengHindawi LimitedThe Scientific World Journal2356-61401537-744X2014-01-01201410.1155/2014/424513424513Solid Tumor-Targeting Theranostic Polymer Nanoparticle in Nuclear Medicinal FieldsAkira Makino0Shunsaku Kimura1Biomedical Imaging Research Center (BIRC), University of Fukui, Fukui 910-1193, JapanDepartment of Material Chemistry, Graduate School of Engineering, Kyoto University, Kyoto 615-8510, JapanPolymer nanoparticles can be prepared by self-assembling of amphiphilic polymers, and various types of molecular assemblies have been reported. In particular, in medicinal fields, utilization of these polymer nanoparticles as carriers for drug delivery system (DDS) has been actively tried, and some nanoparticulate drugs are currently under preclinical evaluations. A radionuclide is an unstable nucleus and decays with emission of radioactive rays, which can be utilized as a tracer in the diagnostic imaging systems of PET and SPECT and also in therapeutic purposes. Since polymer nanoparticles can encapsulate most of diagnostic and therapeutic agents with a proper design of amphiphilic polymers, they should be effective DDS carriers of radionuclides in the nuclear medicinal field. Indeed, nanoparticles have been recently attracting much attention as common platform carriers for diagnostic and therapeutic drugs and contribute to the development of nanotheranostics. In this paper, recent developments of solid tumor-targeting polymer nanoparticles in nuclear medicinal fields are reviewed.http://dx.doi.org/10.1155/2014/424513
collection DOAJ
language English
format Article
sources DOAJ
author Akira Makino
Shunsaku Kimura
spellingShingle Akira Makino
Shunsaku Kimura
Solid Tumor-Targeting Theranostic Polymer Nanoparticle in Nuclear Medicinal Fields
The Scientific World Journal
author_facet Akira Makino
Shunsaku Kimura
author_sort Akira Makino
title Solid Tumor-Targeting Theranostic Polymer Nanoparticle in Nuclear Medicinal Fields
title_short Solid Tumor-Targeting Theranostic Polymer Nanoparticle in Nuclear Medicinal Fields
title_full Solid Tumor-Targeting Theranostic Polymer Nanoparticle in Nuclear Medicinal Fields
title_fullStr Solid Tumor-Targeting Theranostic Polymer Nanoparticle in Nuclear Medicinal Fields
title_full_unstemmed Solid Tumor-Targeting Theranostic Polymer Nanoparticle in Nuclear Medicinal Fields
title_sort solid tumor-targeting theranostic polymer nanoparticle in nuclear medicinal fields
publisher Hindawi Limited
series The Scientific World Journal
issn 2356-6140
1537-744X
publishDate 2014-01-01
description Polymer nanoparticles can be prepared by self-assembling of amphiphilic polymers, and various types of molecular assemblies have been reported. In particular, in medicinal fields, utilization of these polymer nanoparticles as carriers for drug delivery system (DDS) has been actively tried, and some nanoparticulate drugs are currently under preclinical evaluations. A radionuclide is an unstable nucleus and decays with emission of radioactive rays, which can be utilized as a tracer in the diagnostic imaging systems of PET and SPECT and also in therapeutic purposes. Since polymer nanoparticles can encapsulate most of diagnostic and therapeutic agents with a proper design of amphiphilic polymers, they should be effective DDS carriers of radionuclides in the nuclear medicinal field. Indeed, nanoparticles have been recently attracting much attention as common platform carriers for diagnostic and therapeutic drugs and contribute to the development of nanotheranostics. In this paper, recent developments of solid tumor-targeting polymer nanoparticles in nuclear medicinal fields are reviewed.
url http://dx.doi.org/10.1155/2014/424513
work_keys_str_mv AT akiramakino solidtumortargetingtheranosticpolymernanoparticleinnuclearmedicinalfields
AT shunsakukimura solidtumortargetingtheranosticpolymernanoparticleinnuclearmedicinalfields
_version_ 1725265056132759552